New combo therapy for lupus kidney disease shows promise in asian trial
NCT ID NCT02630628
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested two different drug combinations for people with active lupus nephritis, a serious kidney condition caused by lupus. It compared tacrolimus plus steroids against mycophenolate mofetil plus steroids. The goal was to see which combination better controlled kidney disease and prevented flare-ups. 130 adults from Asia took part in this Phase 3 trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUPUS NEPHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The University of Hong Kong
Hong Kong, Hong Kong